Literature DB >> 11431415

Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to V(alpha)14 NKT cells.

N Kamada1, H Iijima, K Kimura, M Harada, E Shimizu, T Kawano, H Shinkai, T Nakayama, T Sakai, L Brossay, M Kronenberg, M Taniguchi.   

Abstract

A novel lymphocyte, NKT cells bearing an invariant V(alpha)14 antigen receptor, specifically recognizes alpha-galactosylceramide (alpha-GalCer) exclusively presented by mouse CD1d (mCD1d). However, the precise molecular interaction remains unclear. For the basis of functional analyses, a docking model of alpha-GalCer with the crystal structure of mCD1d was constructed. Possible residues involved in the alpha-GalCer--mCD1d interaction were found to be Arg79, Glu83 and Asp80 for carbohydrate recognition, and Asp153 for interaction with the amide group on the fatty acyl chain. The alpha-GalCer-presenting ability of various transfectants expressing mutant mCD1d was completely abrogated if a single amino acid mutation was induced at positions 79, 80, 83 or 153, suggesting that the polar amino acids above the F' pocket are crucial for alpha-GalCer presentation to activate V(alpha)14 NKT cells. The possibility that Glu83 is a contact site for the NKT cell receptor is also discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431415     DOI: 10.1093/intimm/13.7.853

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  11 in total

1.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.

Authors:  Dirk M Zajonc; Carlos Cantu; Jochen Mattner; Dapeng Zhou; Paul B Savage; Albert Bendelac; Ian A Wilson; Luc Teyton
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

Review 2.  Valpha14 NKT cell-mediated anti-tumor responses and their clinical application.

Authors:  Ken-Ichiro Seino; Shin-Ichiro Fujii; Michishige Harada; Shinichiro Motohashi; Toshinori Nakayama; Takehiko Fujisawa; Masaru Taniguchi
Journal:  Springer Semin Immunopathol       Date:  2005-01-14

3.  Next Generation Sequencing of the Pig αβ TCR Repertoire Identifies the Porcine Invariant NKT Cell Receptor.

Authors:  Guan Yang; Bianca L Artiaga; Carrie L Lomelino; Anitha D Jayaprakash; Ravi Sachidanandam; Robert Mckenna; John P Driver
Journal:  J Immunol       Date:  2019-02-18       Impact factor: 5.422

4.  Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells.

Authors:  Michael I Zimmer; Hanh P Nguyen; Bin Wang; Honglin Xu; Angela Colmone; Kyrie Felio; Hak-Jong Choi; Ping Zhou; Maria-Luisa Alegre; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

Review 5.  CD1 mediated T cell recognition of glycolipids.

Authors:  Dirk M Zajonc; Mitchell Kronenberg
Journal:  Curr Opin Struct Biol       Date:  2007-10-24       Impact factor: 6.809

6.  Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.

Authors:  Barbara A Sullivan; Niranjana A Nagarajan; Gerhard Wingender; Jing Wang; Iain Scott; Moriya Tsuji; Richard W Franck; Steven A Porcelli; Dirk M Zajonc; Mitchell Kronenberg
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

Review 7.  Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.

Authors:  Enrico Girardi; Dirk M Zajonc
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

8.  A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.

Authors:  Lars Kjer-Nielsen; Natalie A Borg; Daniel G Pellicci; Travis Beddoe; Lyudmila Kostenko; Craig S Clements; Nicholas A Williamson; Mark J Smyth; Gurdyal S Besra; Hugh H Reid; Mandvi Bharadwaj; Dale I Godfrey; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2006-02-27       Impact factor: 14.307

Review 9.  Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy.

Authors:  Masaru Taniguchi; Michishige Harada; Nyambayar Dashtsoodol; Satoshi Kojo
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2015       Impact factor: 3.493

10.  A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.

Authors:  Kwok S Wun; Natalie A Borg; Lars Kjer-Nielsen; Travis Beddoe; Ruide Koh; Stewart K Richardson; Meena Thakur; Amy R Howell; James P Scott-Browne; Laurent Gapin; Dale I Godfrey; James McCluskey; Jamie Rossjohn
Journal:  J Exp Med       Date:  2008-03-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.